Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA GLENMARK PHARMA AJANTA PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 38.3 -31.4 - View Chart
P/BV x 8.3 2.9 291.1% View Chart
Dividend Yield % 0.3 0.3 119.8%  

Financials

 AJANTA PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
AJANTA PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,426487 292.7%   
Low Rs1,062349 304.4%   
Sales per share (Unadj.) Rs297.2460.4 64.6%  
Earnings per share (Unadj.) Rs46.713.4 349.1%  
Cash flow per share (Unadj.) Rs57.135.0 162.9%  
Dividends per share (Unadj.) Rs7.002.50 280.0%  
Avg Dividend yield %0.60.6 94.1%  
Book value per share (Unadj.) Rs269.1335.1 80.3%  
Shares outstanding (eoy) m125.91282.17 44.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.20.9 460.9%   
Avg P/E ratio x26.631.3 85.2%  
P/CF ratio (eoy) x21.811.9 182.7%  
Price / Book Value ratio x4.61.2 370.7%  
Dividend payout %15.018.7 80.2%   
Avg Mkt Cap Rs m156,638117,953 132.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,85127,810 28.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,426129,901 28.8%  
Other income Rs m9863,168 31.1%   
Total revenues Rs m38,413133,069 28.9%   
Gross profit Rs m7,83315,125 51.8%  
Depreciation Rs m1,3086,113 21.4%   
Interest Rs m583,496 1.7%   
Profit before tax Rs m7,4538,685 85.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5734,911 32.0%   
Profit after tax Rs m5,8803,774 155.8%  
Gross profit margin %20.911.6 179.7%  
Effective tax rate %21.156.5 37.3%   
Net profit margin %15.72.9 540.7%  
BALANCE SHEET DATA
Current assets Rs m28,25298,737 28.6%   
Current liabilities Rs m11,39350,455 22.6%   
Net working cap to sales %45.037.2 121.2%  
Current ratio x2.52.0 126.7%  
Inventory Days Days667 982.7%  
Debtors Days Days10115 9.0%  
Net fixed assets Rs m18,70776,920 24.3%   
Share capital Rs m253282 89.6%   
"Free" reserves Rs m33,62494,281 35.7%   
Net worth Rs m33,87794,563 35.8%   
Long term debt Rs m1338,521 0.0%   
Total assets Rs m47,047175,658 26.8%  
Interest coverage x128.63.5 3,691.2%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 107.6%   
Return on assets %12.64.1 305.0%  
Return on equity %17.44.0 434.9%  
Return on capital %22.29.2 242.2%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,42046,464 48.3%   
Fx outflow Rs m4,29312,712 33.8%   
Net fx Rs m18,12733,751 53.7%   
CASH FLOW
From Operations Rs m7,9186,254 126.6%  
From Investments Rs m-5,596-5,285 105.9%  
From Financial Activity Rs m-1,079-775 139.3%  
Net Cashflow Rs m1,243325 382.5%  

Share Holding

Indian Promoters % 66.2 46.7 141.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 34.7 74.4%  
FIIs % 9.1 23.7 38.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 53.4 63.3%  
Shareholders   54,351 209,931 25.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Glenmark Pharma Share Price Performance

Period AJANTA PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day 2.51% -0.57% 1.18%
1-Month 7.60% 5.16% -0.75%
1-Year 92.91% 112.94% 61.82%
3-Year CAGR 21.63% 27.51% 18.16%
5-Year CAGR 26.85% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.